At Ferozsons, it's your health before anything else! We strive to attain market leadership by putti fields. The new wing will be operational in early 2013.
The Corporate History of the Ferozsons Group began in 1894, when its Founder Maulvi Ferozuddin Khan established the Ferozsons publishing house. From the outset, our founder’s corporate vision involved playing a meaningful role in the education and health of the underprivileged population of the sub-continent. Consequently, Ferozsons Laboratories Limited was created in 1954 as one of the first pharmaceutical manufacturing facilities in the fledgling state of Pakistan. The company commenced operations in 1956, and in 1960 became the first Pakistani pharmaceutical company to be lister on the Karachi Stock Exchange. We have a consistent track record of financial performance, and are a 6-time recipient of the Karachi Stock Exchange's 'KSE Top 25 Companies Award.'
Through our range of branded generics and in-licensed products , we have attained market leadership in the areas of cardiology , oncology, gastroenterology, dermatology and anti-infective markets in the Pakistan. These products are now being exported to markets in Asia and Africa, and we are actively seeking export opportunities in other markets. Ferozsons is the Pakistan marketing and distribution partner for the Boston Scientific Corporation, USA for its range of cardiac and peripheral products and interventional devices. This partnership will allow us to further strengthen our channels in cardiology , oncology, and G.I. We offer principals an excellent manufacturing, marketing and distribution platform for launching their products in the Pakistan market. Our cGMP compliant production facility in Nowshera is ISO 9001 certified and we are fully equipped with state of the art manufacturing and testing equipment. The facility consists of independent sections, each with its own dedicated air handling system to avoid cross-contamination between different classes of drugs being manufactured. Our production capabilities include the manufacturing of tablets, capsules, syrups, suspensions, creams and ointments. Our facility control laboratory is among the best equipped in the industry and possesses Malver Particle Size Analyzers, High Performance Liquid Chromatographs (HPLC), Gas Chromatograph (GC), Fourier Transfer-IR Spectrophotometer and UV-Visible spectrometers, in addition to dissolution, disintergration, hardness and friability testers. In 2012, the Company undertook a major expansion in its manufacturing, adding a new production wing for the production of solid dosage forms.
13/02/2026
at the – kicking off 2026 in collaboration with to foster critical conversations on emerging clinical gastro-metabolic challenges.
With over 80+ gastroenterologists, medical specialists, and general physicians in attendance, the forum fostered evidence-based dialogue addressing real-world GERD challenges and evolving management strategies.
Together, strengthening collaboration for better patient outcomes.
05/02/2026
We stand in solidarity with the people of Kashmir, honouring their resilience and right to peace, dignity, and self-determination.
04/02/2026
Ferozsons Laboratories Limited extends warm wishes to the people of Sri Lanka on the occasion of Independence Day. May this day celebrate freedom, resilience, and continued progress for the nation. 🇱
04/02/2026
On this we join the global effort to raise awareness, encourage timely , and promote informed action.
Early Detect, Early Protect—because early diagnosis remains one of the most effective tools in the fight against cancer.
World Cancer Day
03/02/2026
Ferozsons Laboratories Limited and BF Biosciences Limited are heading to
We’re excited to be part of the WHX Dubai (formerly Arab Health), a premier platform for global healthcare innovation and collaboration.
📍 Booth 3.B10
🗓 February 9- 12, 2026
🏢 Dubai Exhibition Center (DEC)
Explore our innovations, connect with our team, and discover our value mission of
Let’s connect, collaborate, and grow—globally.
19/01/2026
We are pleased to announce the signing of a Memorandum of Understanding (MoU) between Ferozsons Laboratories Limited and@marhampk
Ferozsons Laboratories Limited & have partnered to raise about health through easy-to-access, impactful digital content under the public health initiative Ab Baat Hogi Dil Ki
31/12/2025
Happy New Year!!
As we welcome the New Year, we thank our partners, healthcare professionals, and communities for their trust. A new year, a shared hope for better health. Wishing everyone a healthy year ahead.
26/12/2025
We are pleased to announce the signing of a Memorandum of Understanding (MoU) between Ferozsons Laboratories Limited and The Pakistan Society of Health System- Pharmacists . This strategic collaboration marks a significant step toward enhancing pharmacovigilance and medication safety capabilities among 1000+ pharmacists nationwide.
Through structured, compliant, and needs-based capacity building, the initiative aims to enhance professional competencies, support patient safety, and contribute meaningfully to healthcare capacity-building across Pakistan.
25/12/2025
Remembering Quaid-e-Azam Muhammad Ali Jinnah—whose reminds us that , , and integrity are the foundation of a stronger nation and future.
28/11/2025
This , we turned awareness into action!
From checks and screenings to activities and expert-led guidance session — our teams at Ferozsons Laboratories Limited & BF Biosciences Limited came together to own their wellbeing at workplace.
Dr. Prof. , leading , elevated the event with an engaging and interactive session with the employees on practical lifestyle changes for a healthier workplace.
Together, we aim to turn the tide against diabetes — one habit at a time.
26/11/2025
Iron Deficiency affects 1 in 3 people worldwide. Signs that you are iron deficient can include Fatigue , Dizziness , Shortness of breath and others.
The natural stages of a woman’s life can increase her risk of iron deficiency. Blood loss during menstruation, pregnancy, or post-birth is a time when there is a potential for the development of iron deficiency.
Consult your Doctor today and get tested.
14/11/2025
Pakistan faces a tidal wave of metabolic diseases including diabetes and obesity.
Did you know? Pakistan has the highest prevalence of Diabetes in the world with more than 34 M adults living with the disease. We also rank 10th in Obesity among 188 countries.
Be the first to know and let us send you an email when Ferozsons Laboratories Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The foundations of the Ferozsons business group were laid in 1894 by Maulvi Ferozuddin Khan, who founded the Ferozsons publishing house. From the outset, the group’s corporate vision involved playing a meaningful role in the education and health of the underprivileged population of the sub-continent. Ferozsons Laboratories Limited was thus established in 1956 as one of the first Pharmaceutical manufacturing companies in Pakistan, and has now entered its seventh decade of serving the cause of health and well- being in Pakistan and a growing number of international markets.
In 1960, we became the first Pakistani pharmaceutical company to be listed on the Karachi Stock Exchange (KSE) Limited, and have a consistent track record of delivering on our financial objectives. The company is a multiple-time recipient of the KSE Top 25 Companies Award.
Ferozsons set the standards for the strict adherence to Global Standards of Quality Control and Good Manufacturing Practices, achieving International acclaim and recognition soon after its incorporation. The company remained a major supplier to the Federal Supply Services, Government of U.S.A, The British Crown Agents, the United Nations, various international relief agencies besides exporting to many developed countries including Australia, Iran, Hong Kong, Jordan, Saudi Arabia, Singapore, Sri Lanka, Sudan, Tanzania, Thailand, Turkey and the U.A.E.
The company has a long and highly successful history of collaborations with various multinational companies in the past, including Boots Pharmaceuticals PLC of U.K, Chemie Grunenthal GmbH, Germany, Lakeside laboratories U.S.A, Orgasynth Laboratories of France and Proctor & Gamble, U.S.A.
Now the company has expanded its portfolio of medical solutions for critical diseases by forging alliances with some of the world’s most innovative companies including Gilead Sciences, Inc., a global leader in the treatment of HIV and Viral Hepatitis, the Boston Scientific Corporation, USA the world’s leading manufacturer of medical devices, and a joint venture in biopharmaceuticals with the Bagó Group of Argentina. We also have partnerships with BioGaia of Sweden for a line of probiotics as well as Performance Health, Inc. USA for the brand, Biofreeze pain relief products.